Looking for a new broker?
Protagenic Therapeutics, Inc. stock is up 10.26% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 29.17% of the previous 26 November’s closed higher than October.
Protagenic Therapeutics, Inc. engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide.
